Zobrazeno 1 - 10
of 97
pro vyhledávání: '"M. Antimi"'
Autor:
P. Mazza, S. Tura, M. Bocchia, P. L. Zinzani, F. Gherlinzoni, F. Mandelli, M. P. Anselmo, G. Papa, M. Antimi, P. G. Gobbi, A. Porcellini, V. Rizzoli, L. Resegotti, A. Levis, L. Deriu, A. Chierichini, F. Ciccone, R. Fanin, G. Castoldi, G. L. Scapoli, V. Liso, T. Chisesi, L. Rancan, B. Amurri
Publikováno v:
European Journal of Haematology. 45:22-24
In an ongoing phase II study we are evaluating the role of alpha-2b recombinant interferon in Hodgkin's disease; the study design includes patients with high-risk parameters who are treated by combination chemotherapy MOPP, ABVD, MOPP + ABVD or equiv
Autor:
G.L Frassineti, G. Luporini, Vito Lorusso, C.F Pollera, M. Antimi, M. De Lena, C. Gridelli, C. Oliva, M Pacini
Publikováno v:
European Journal of Cancer. 34:1208-1212
The aim of this study was to evaluate the efficacy and safety of gemcitabine, a pyrimidine antimetabolite, in the treatment of advanced transitional cell carcinoma of the urinary tract. 35 patients with unresectable or metastatic transitional cell ca
Autor:
F. Cognetti, E.M. Ruggeri, A. Felici, M. Gallucci, G. Muto, C.F. Pollera, B. Massidda, A. Rubagotti, D. Giannarelli, F. Boccardo, R. Cantiani, M. Aglietta, O. Bertetto, G.L. Cetto, P. Orlandini, E. Ferrazzi, M. Nardi, Sollievo della Sofferenza, L. Manzione, V. Adamo, G. Porcile, M. Lentini, E. Breda, T. Gamucci, D. Tummarello, L. Dogliotti, S. Tumolo, M. Motta, V. Lo Russo, G. De Grande, C. Sacco, F. Gaion, A. Lavarello, A. Nuzzo, M. Clerico, C. Aragona, A. Gernone, F. Morelli, V. Olivito, null Cupini, R. Mattioli, A. Marra, M. Antimi, V. Silingardi, R. Labianca, A. Martoni, V. Bortolussi, M. Luoni, A. Rosabian, F. Di Vito, G. Catalano, N. Gebbia
Background The purpose of the study was to evaluate the benefit of adjuvant chemotherapy (AC) versus surgery alone in patients with muscle-invasive bladder cancer (MIBC). Patients and methods One hundred and ninety-four patients with pT2G3, pT3–4,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6929c34f62b572c625dc171db791cf6
http://hdl.handle.net/2318/134005
http://hdl.handle.net/2318/134005
Publikováno v:
La Clinica terapeutica. 159(2)
Stage of disease at diagnosis and histologic type according to WHO classification are the most important prognostic factors for thymoma and complete surgical resection represents a crucial point for disease free survival. When surgery is not feasible
Autor:
Sante Tura, Patrizio Mazza, Michele Baccarani, Cesare Guglielmi, Paolo G. Gobbi, Teodoro Chisesi, Vittorio Rizzoli, Franco Gherlinzoni, Dini E, Renato Fanin, M. F. Martelli, M. Antimi, Lina Mangoni, Pier Luigi Zinzani, A. Porcellini, Franco Mandelli, Gian Luigi Castoldi, Annunziata Manna, P. Rossi Ferrini, Francesco Lanza, Antonio Tabilio, G. Bellesi, Edoardo Ascari, Giuseppe Papa
Publikováno v:
Blut. 60:172-176
In a phase II cooperative study involving eleven Italian haematological units, the efficacy and toxicity of a new alkylating compound, PTT-119, was evaluated in 53 patients with non-Hodgkin's lymphoma (NHL). Forty-five of the patients had been previo
Publikováno v:
La Clinica terapeutica. 155(7-8)
In ninety's breast cancer was first in Europe for the use of high-dose chemotherapy with autologous hematopoietic stem cell transplantation in solid tumors in adults. Some phase II trials of high-dose chemotherapy showed high response rates and prolo
Autor:
C. Presot, M. S. Dionisi, A. Lucenti, M. Minelli, M. Antimi, P. Manente, Massimo Federico, E. Sansoni, C. M. Foggi, T. Buniva, D. Negri, Giovanni Quarta, Albano Del Favero, Maurizio Tonato, D. Amadori, C. Epifani, M. Maltoni, G. Gorzegno, M. Giordano, C. Milandri, R. Casaretti, G. Ciccarese, P. Marchei, F. De Vita, I. Carreca, V. Fosser, D. Donati, G. Cruciani, S. Della Gaspera, F. M. Gioffré, L. De Sio, B. Agostara, Verena De Angelis, Roberto Sabbatini, Fausto Roila, R. Sabbioni, R. Maccaferri, G. Villani, G. Bernardo, M. R. Strada, A. Contu, G. Amunni, A. Villanucci, S. Schiavon, S. Tumolo, A. Pazzola, C. Caroti, L. Merlini, A. Amodio, M. Marzi, G. Garofolo, G. Catalano, L. Dogliotti, P. Alessadroni, P. Malacarne, M. Ceccolini, F. Conti, F. Di Costanzo, L. Rausa, M. A. Palladino, M. Lopez, L. Montanari, L. Gallo, G. Iodice, G. L. Cetto, A. Venuti, S. Mazzotta, M. T. Cattaneo, C. Pacilio, G. Palmiotti, R. Nortilli, R. Forcignanò, G. Troccoli, A. Giglio, G. Comella, G. Rosati, Enzo Ballatori, S. Amici, Roberta Depenni, Vittorio Silingardi, S. Porrozzi, L. Meneghetti, G. Muran, B. Orlandini
Publikováno v:
Scopus-Elsevier
Aims and Background The necessity of an antiemetic prophylaxis in patients treated with chemotherapy of low emetogenic potential, such as 5-fluorouracil ± folinic acid fractionated over several consecutive days, is controversial. The aim of the stud
Publikováno v:
La Clinica terapeutica. 151(6)
Anaplastic carcinoma, insular carcinoma and medullary carcinoma (both familiar and sporadic forms) represent the 7-25% of all thyroid tumors. Anaplastic carcinoma is one of most aggressive human tumors and the therapeutic options proposed have failed
Publikováno v:
La Clinica terapeutica. 151(5)
Differentiated thyroid carcinomas are TSH-dependent tumors induced by genetic and environmental factors. They may be found on 3-12% of single thyroid lesions. Females are more affected than males (F:M 3:1). The combined action of genetic and environm
Autor:
M, Michetti, M, Minelli, C, Berni, V, Bellini, A, La Porta, L, Manente, G, Marinuzzi, M, Antimi
Publikováno v:
La Clinica terapeutica. 150(4)
Primary non-Hodgkin's lymphomas (NHL) of the breast represent less than 3% of extranodal NHL; in comparison to extranodal NHL at other sites, they are characterized by rapid progression and worse prognosis. We report a case of primary NHL of the brea